dc.contributor.author |
Triboi, Valentina |
|
dc.date.accessioned |
2022-06-09T11:28:19Z |
|
dc.date.available |
2022-06-09T11:28:19Z |
|
dc.date.issued |
2022 |
|
dc.identifier.citation |
TRIBOI, Valentina. Nanomedicine as the future of medicine. In: MedEspera: the 9th International Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2022, p.126. |
en_US |
dc.identifier.uri |
https://medespera.asr.md/en/books?page=1 |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/20967 |
|
dc.description.abstract |
Introduction. Every day we face health problems, especially with chronic diseases and their damage to
people and the health system. That’s why it is important and necessary to find a solution for them and
nanomedicine can be this solution.
Aim of study. The objective of this research is to evaluate the role of nanomedicine in our health system
and how nanoparticles work at different levels of our bodies.
Methods and materials. Were analysed PubMed articles published from 2012 to 2022, on the subject of
nanomedicine and nanoparticles used in medicine. It is obvious that their number increases every year.
Results. The result of the study confirm that nanomedicine presents revolutionary opportunities in different
types of cancer (recent progress in physics, chemistry and science of materials have provided nanomaterials
that are expected to improve the treatment of many tumors resistant to current therapies), neurodegenerative
and cardiovascular diseases, infections and other pathologies, with the help of miniature devices and
nanoparticles. Nanotechnology is used as a tool to explore the darkest paths of medicine through imaging,
targeted medication, delivery of gene systems and implants. The countries with the highest percentages of
articles about nanomedicine were Europe (36%) and the United States (39%). In the rapidly growing
nanomedicine market, an increasing number of items whose therapeutic efficacy has been enhanced by
their nanoscale dimensions are already accessible. Furthermore, hundreds of nano based products are in
various phases of preclinical and clinical research. The United States Food and Drug Administration has
authorized over 20 nanomedicine products in the last 22 years. Despite the large number of papers and
studies on nanoformulation of drugs, only a limited number of such nanosystems have advanced to marketrelated assessment, and an even smaller number have achieved final approval. According to some statistics,
less than 10% of scientific findings get translated into clinical applications.
Conclusion. Nanomedicine offers us the capacity to prevent diseases, to find an early diagnosis and to treat
pathologies at the molecular level. So, nanomedicine may change the current methods of diagnosis,
treatment and will lead to new solutions and directions in research. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Association of Medical Students and Residents |
en_US |
dc.relation.ispartof |
MedEspera: The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022, Chisinau, Republic of Moldova |
en_US |
dc.title |
Nanomedicine as the future of medicine |
en_US |
dc.type |
Other |
en_US |